news
Researchers report that reduced TDP-43 expression disrupts axonal transport of…
23 September 2020 | By Hannah Balfour (Drug Target Review)
Researchers report that reduced TDP-43 expression disrupts axonal transport of messenger RNAs to cause neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD).